Clinical trial
DAPTO-SNAP: Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332 is registered in ClinicalTrials.gov with Todd C. Lee MD MPH FIDSA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DAPTO-SNAP: Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
- Lead sponsor
- Todd C. Lee MD MPH FIDSA
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 14, 2024
- Completion date
- November 30, 2029
- Enrollment
- 300 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
s. aureus bacteremia, s. aureus bloodstream infection, staphylococcus aureus bacteremia, staphylococcus aureus endocarditis, staphylococcus aureus septicemia